Literature DB >> 21739529

Pax7 expressing cells contribute to dermal wound repair, regulating scar size through a β-catenin mediated process.

Saeid Amini-Nik1, Dylan Glancy, Corey Boimer, Heather Whetstone, Charles Keller, Benjamin A Alman.   

Abstract

During skin wound healing, fibroblast-like cells reconstitute the dermal compartment of the repaired skin filling the wound gap. A subset of these cells are transcriptionally active for β-catenin/T-cell factor (TCF) signaling during the proliferative phase of the repair process, and β-catenin levels control the size of the scar that ultimately forms by regulating the number of dermal fibroblasts. Here, we performed cell lineage studies to reveal a source of the dermal cells in which β-catenin signaling is activated during wound repair. Using a reporter mouse, we found that cells in the early wound in which TCF-dependent transcription is activated express genes involved in muscle development. Using mice in which cells express Pax7 (muscle progenitors) or Mck (differentiated myocytes) are permanently labeled, we showed that one quarter of dermal cells in the healing wound are Pax7 expressing progeny, but none are Mck progeny. Removing one allele of β-catenin in Pax7 expressing progeny resulted in a significantly smaller scar size with fewer Pax7 expressing progeny cell contributing to wound repair. During wound healing, β-catenin activation causes muscle satellite cells to adopt a fibrotic phenotype and this is a source of dermal cells in the repair process.
Copyright © 2011 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739529     DOI: 10.1002/stem.688

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  27 in total

Review 1.  Palatogenesis and cutaneous repair: A two-headed coin.

Authors:  Leah C Biggs; Steven L Goudy; Martine Dunnwald
Journal:  Dev Dyn       Date:  2014-11-25       Impact factor: 3.780

2.  Promotion of dermal regeneration using pullulan/gelatin porous skin substitute.

Authors:  Nan Cheng; Marc G Jeschke; Mohammadali Sheikholeslam; Andrea-Kaye Datu; Hwan Hee Oh; Saeid Amini-Nik
Journal:  J Tissue Eng Regen Med       Date:  2019-08-08       Impact factor: 3.963

Review 3.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

4.  Many roles for Pax7.

Authors:  Józef Dulak
Journal:  Cell Cycle       Date:  2016-10-20       Impact factor: 4.534

Review 5.  Methodologies in creating skin substitutes.

Authors:  Mathew N Nicholas; Marc G Jeschke; Saeid Amini-Nik
Journal:  Cell Mol Life Sci       Date:  2016-05-06       Impact factor: 9.261

Review 6.  Animal models in burn research.

Authors:  A Abdullahi; S Amini-Nik; M G Jeschke
Journal:  Cell Mol Life Sci       Date:  2014-04-09       Impact factor: 9.261

7.  Examining the contribution of surrounding intact skin during cutaneous healing.

Authors:  Makram E Aljghami; Marc G Jeschke; Saeid Amini-Nik
Journal:  J Anat       Date:  2019-02-20       Impact factor: 2.610

8.  Substrate modulus of 3D-printed scaffolds regulates the regenerative response in subcutaneous implants through the macrophage phenotype and Wnt signaling.

Authors:  R Guo; A R Merkel; J A Sterling; J M Davidson; S A Guelcher
Journal:  Biomaterials       Date:  2015-09-11       Impact factor: 12.479

9.  Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype.

Authors:  Shingo Sato; Yuning J Tang; Qingxia Wei; Makoto Hirata; Angela Weng; Ilkyu Han; Atsushi Okawa; Shu Takeda; Heather Whetstone; Puvindran Nadesan; David G Kirsch; Jay S Wunder; Benjamin A Alman
Journal:  Cell Rep       Date:  2016-07-14       Impact factor: 9.423

Review 10.  Wnt/catenin signaling in adult stem cell physiology and disease.

Authors:  Alexander Ring; Yong-Mi Kim; Michael Kahn
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.